- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
SYNAGIS - 50mg/0.5ml - 1x0.5ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J06BD01 | BioTech | Palivizumab - 50mg/0.5ml | 11749 | 104121/1 | SYNAGIS | 50mg/0.5ml | 1x0.5ml | Injectable solution | IM | Omnipharma | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 38,316,693 L.L | 19.35 | D | AstraZeneca AB | Sweden | 2/5/2024 | 0 |